AnaptysBio, Inc. (ANAB)
45.95
-0.26
(-0.56%)
USD |
NASDAQ |
Oct 09, 16:00
46.00
+0.05
(+0.11%)
After-Hours: 20:00
AnaptysBio Price to Book Value : 129.05 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 129.05 |
| October 08, 2026 | 129.78 |
| October 07, 2026 | 128.21 |
| October 06, 2026 | 134.50 |
| October 05, 2026 | 138.18 |
| October 02, 2026 | 136.30 |
| October 01, 2026 | 136.58 |
| September 30, 2026 | 141.16 |
| September 29, 2026 | 141.46 |
| September 28, 2026 | 142.67 |
| September 25, 2026 | 143.23 |
| September 24, 2026 | 145.20 |
| September 23, 2026 | 142.59 |
| September 22, 2026 | 151.43 |
| September 21, 2026 | 154.24 |
| September 18, 2026 | 155.03 |
| September 17, 2026 | 154.64 |
| September 16, 2026 | 152.53 |
| September 15, 2026 | 153.57 |
| September 14, 2026 | 151.97 |
| September 11, 2026 | 151.29 |
| September 10, 2026 | 154.92 |
| September 09, 2026 | 156.43 |
| September 08, 2026 | 158.96 |
| September 04, 2026 | 159.52 |
| Date | Value |
|---|---|
| September 03, 2026 | 161.38 |
| September 02, 2026 | 156.83 |
| September 01, 2026 | 155.25 |
| August 31, 2026 | 160.17 |
| August 28, 2026 | 158.06 |
| August 27, 2026 | 160.90 |
| August 26, 2026 | 162.89 |
| August 25, 2026 | 163.93 |
| August 24, 2026 | 164.13 |
| August 21, 2026 | 162.16 |
| August 20, 2026 | 159.21 |
| August 19, 2026 | 166.43 |
| August 18, 2026 | 165.67 |
| August 17, 2026 | 167.64 |
| August 14, 2026 | 164.21 |
| August 13, 2026 | 157.33 |
| August 12, 2026 | 160.03 |
| August 11, 2026 | 162.53 |
| August 10, 2026 | 155.79 |
| August 07, 2026 | 158.99 |
| August 06, 2026 | 153.82 |
| August 05, 2026 | 154.44 |
| August 04, 2026 | 154.83 |
| August 03, 2026 | 150.70 |
| July 31, 2026 | 149.86 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 19.19 |
| Anika Therapeutics, Inc. | 1.909 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.203 |
Price to Book Value Related Metrics
| PE Ratio | 7.129 |
| PS Ratio | 5.742 |
| Price to Free Cash Flow | 75.52 |
| Price | 45.95 |
| Earnings Yield | 14.03% |
| Market Cap | 1.366B |
| Operating PE Ratio | 10.19 |
| Normalized PE Ratio | 7.128 |